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impact the epidemiology of pertussis in the US.
Michael Ohl, MD, University of Missouri–Columbia
Does quinine reduce 
leg cramps 
for young athletes?
■ EVIDENCE-BASED ANSWER
Very little evidence exists regarding the use of
quinine for cramps in young adult athletes.
Quinine may be an effective treatment for heat
cramps in athletes (strength of recommendation
[SOR]: C, 1 case series involving 2 patients).
Quinine is better established as an effective treat-
ment for nocturnal leg cramps in the general adult
population (SOR: A, 1 meta-analysis and 2 ran-
domized controlled trials).
■ EVIDENCE SUMMARY
Leg cramps (heat cramps) in athletes are
defined as painful involuntary muscle contrac-
tions, usually in the large muscle groups of the
legs, which occur during or in the hours follow-
ing exercise. Oral quinine is sometimes used to
treat nocturnal leg cramps in the general adult
and elderly populations. However, its use is 
controversial secondary to concerns regarding
efficacy and safety.
Efficacy of quinine in young athletes has not
been well studied. A case series reported on 
2 athletes: 1 college basketball player and 
1 professional football player.1 The basketball
player experienced heat cramps during games
that were resistant to hydration and dietary treat-
ment. A regimen of 60 mg oral quinine sulfate
taken 1 hour before game time and again at half-
time eliminated cramps during the first game and
the subsequent 15 games. The football player’s
heat cramps were only partially improved with
oral electrolyte repletion and oral hydration.
However, he suffered no further cramps after ini-
tiating a regimen of 120 mg oral quinine sulfate
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■ CLINICAL COMMENTARY
Infants may have complications; evaluate
if there is apnea or significant cough
Immunity to pertussis wanes following vaccina-
tion, leaving many adolescents and adults sus-
ceptible to infection. In older children and adults,
there is often little in the clinical presentation
that distinguishes chronic cough due to pertussis
from that associated with other causes.
Clinicians should consider evaluating for pertus-
sis in older children and adults with chronic
cough (>2 weeks) if there is reason to suspect
they have been exposed, if the cough is associat-
ed with inspiratory whoop, or if the individual has
household or frequent contact with infants. 
Infants may suffer severe complications from
pertussis, and should receive evaluation when
presenting with apnea or significant cough of any
duration. In current practice, evaluation usually
includes obtaining a nasopharyngeal swab for
culture and PCR, though these tests may be
insensitive, especially in later phases of illness.
The usefulness of single, quantitative
immunoglobulin G titers with comparison to pop-
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before games and 60 mg oral quinine during
games for an undisclosed period of time. Both
players had normal blood chemistries before
starting quinine. No side effects were mentioned. 
Several trials involving the general adult pop-
ulation exist. A meta-analysis of 4 published
and 3 unpublished reports of randomized, dou-
ble-blind controlled crossover trials (n=409)
showed that adult patients had significantly
fewer nocturnal cramps when taking quinine
compared with placebo.2 The absolute reduction
in number of leg cramps was 3.6 (95% confi-
dence interval [CI], 2.15–5.05) over a 4-week
period, and the relative risk reduction was 0.21
(95% CI, 0.12–0.30).  
Two randomized controlled trials were not
included in the meta-analysis discussed above.
One double-blind, randomized, controlled paral-
lel group trial of 98 adult patients with a mean
age of 50 years demonstrated that a regimen of
daily quinine sulfate therapy of 200 mg with the
evening meal and 200 mg at bedtime signifi-
cantly reduced the number of nocturnal muscle
cramps compared with placebo.3 Over a 2-week
treatment period the quinine group experienced
a median of 8 fewer cramps (95% CI, 7–10),
while the placebo group experienced a median
of 6 fewer cramps (95% CI, 3–7). However,
patient evaluation of global efficacy of treat-
ment was not statistically significant between
the quinine and placebo groups.
A second double-blind, randomized, con-
trolled parallel group trial of 102 adult patients,
mean age approximately 50 years, showed that
a 2-week treatment period of hydroquinine (not
available in the US) also produced a significant
reduction in day- and nighttime muscle cramps
compared with placebo.4 This study used a regi-
men of two 100-mg hydroquinine or placebo
tablets with the evening meal and one 100-mg
tablet or placebo at bedtime. The median differ-
ence in the number of cramps between the treat-
ment and control groups was 5 (95% CI, 2–8). 
It should be noted that during the 2 weeks
immediately following the treatment period, num-
bers of cramps were still low compared with the
pretreatment period and no significant difference
was seen in number of cramps between groups.
This raises suspicion that the improvement in
both groups was due to the self-limited nature of
cramps and represented the regression-to-the-
mean phenomenon rather than a true treatment
effect of hydroquinine. In addition, extrapolating
results from studies of nocturnal cramps to heat
cramps is problematic, as it is unknown whether
these differ in physiology or cause.
Use of quinine for common cramps in nonath-
letes has been controversial. In 1994 the Food
and Drug Administration (FDA) issued a state-
ment banning over-the-counter sale of quinine for
nocturnal leg cramps, citing lack of adequate data
to establish efficacy and concern for potential tox-
icity.5 Between 1969 and 1990 the FDA received
26 adverse reaction reports in which quinine was
concluded to be the causative agent. The 3 stud-
ies discussed above consistently mention only tin-
nitus as likely related to quinine use. However,
the descriptions and inference testing of side
effects were inadequate in each study. 
Of note, quinine is a category X drug and
should not be used during pregnancy.6
■ RECOMMENDATIONS FROM
OTHERS
No specific recommendations exist regarding
the use of quinine in athletes. The American
Medical Society of Sports Medicine recommends
rest, stretching, and oral hydration for simple
heat cramps, and intravenous fluids for very
severe cases.7 Several texts also recommend
rehydration with an oral electrolyte solution, as
well as rest, stretching, and massage.8–10
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be useful in prophylaxis. Once cramps occur,
rehydration, stretching, massage, and rest
work best. 
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Can type 2 diabetes 
be prevented through 
diet and exercise?
■ EVIDENCE-BASED ANSWER
Diets that result in long-term weight loss of 5% to
7%, along with moderate-intensity exercise for
more than 150 minutes per week, reduce the inci-
dence of type 2 diabetes for patients with
impaired glucose tolerance (IGT) (strength of rec-
ommendation [SOR]: A, based on multiple ran-
domized controlled trials [RCTs]). Each of the tri-
als demonstrating this finding included fairly
intensive counseling as part of the successful
intervention. Diet and exercise reduce the inci-
dence of diabetes in both lean (body mass index
[BMI] <25) and overweight patients with IGT
(SOR: B, based on a single, large RCT).
■ EVIDENCE SUMMARY
Three large prospective RCTs evaluated the
effect of dietary and exercise interventions in
populations at risk for developing diabetes. 
The Diabetes Prevention Program
Research Group1 randomized 3234 patients age
>24 years without diabetes but with IGT and a
BMI >24 to 1 of 3 groups: intensive lifestyle
modification, metformin, or control; they then
compared the incidence of diabetes over 3 years.
Patients were men and women from primary
care populations and represented diverse ethnic
backgrounds. Investigators defined IGT as plas-
ma glucose of 140 to 200 mg/dL 2 hours after a
75-g glucose bolus when the fasting glucose
was <140 mg/dL. Intensive lifestyle interven-
tion comprised individual training sessions on a
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■ CLINICAL COMMENTARY
Hydration and salt intake best approach
for cramping in athletes
The use of quinine for the treatment or pre-
vention of leg cramps in young adult athletes is
not well studied. Safety and efficacy issues
make it an unappealing option in the treatment
of cramps and consequently it is not recom-
mended for use in athletes. Hydration before,
during, and after activity remains the corner-
stone to approaching cramping in athletes.
Appropriate salt intake for those who lose high
concentrations of salt in their sweat may also
Hydration before, during, and after
activity remains the cornerstone to
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